André Steven

2.9k total citations
19 papers, 797 citations indexed

About

André Steven is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, André Steven has authored 19 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in André Steven's work include Immunotherapy and Immune Responses (6 papers), Cell Adhesion Molecules Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). André Steven is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cell Adhesion Molecules Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). André Steven collaborates with scholars based in Germany, Sweden and United States. André Steven's co-authors include Barbara Seliger, Rolf Kiessling, Dhifaf Sarhan, Yumeng Mao, Andreas Lundqvist, Michael Friedrich, Carsten Denkert, Jan Budczies, Paul Jank and Claudia Wickenhauser and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Clinical Cancer Research.

In The Last Decade

André Steven

19 papers receiving 790 citations

Peers

André Steven

IMMUN

ONCOL

PRM

Dandan Lv China

Valeria Tarallo Italy

Ami Tamir Israel

Braden C. McFarland United States

Jiayuan Shi United States

David Vindrieux France

Chiara Gabellini Italy

Katherine Drews‐Elger United States

Hsin-Ling Hsu Taiwan

Ben‐Kuen Chen Taiwan

Dandan Lv China

André Steven

357 ×0.9

230 ×0.8

IMMUN

165 ×0.7

ONCOL

168 ×1.1

100 ×1.1

PRM

Citations per year, relative to André Steven André Steven (= 1×) peers Dandan Lv

Countries citing papers authored by André Steven

Since Specialization

Citations

This map shows the geographic impact of André Steven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Steven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Steven more than expected).

Fields of papers citing papers by André Steven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Steven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Steven. The network helps show where André Steven may publish in the future.

Co-authorship network of co-authors of André Steven

This figure shows the co-authorship network connecting the top 25 collaborators of André Steven. A scholar is included among the top collaborators of André Steven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Steven. André Steven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Massa, Chiara, et al.. (2022). Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells. OncoImmunology. 11(1). 2069214–2069214. 7 indexed citations

Wickenhauser, Claudia, Daniel Bethmann, Matthias Kappler, et al.. (2021). Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma. Cancers. 13(4). 620–620. 15 indexed citations

Meyer, Stefanie, Diana Handke, Anja Müeller, et al.. (2021). Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma. Cancers. 13(15). 3907–3907. 7 indexed citations

Friedrich, Michael, Robert Stoehr, André Steven, et al.. (2020). CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma. Scientific Reports. 10(1). 6499–6499. 23 indexed citations

Steven, André, Michael Friedrich, Paul Jank, et al.. (2020). What turns CREB on? And off? And why does it matter?. Cellular and Molecular Life Sciences. 77(20). 4049–4067. 129 indexed citations

Friedrich, Michael, Robert Stoehr, Simon Jasinski‐Bergner, et al.. (2020). Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma. Journal of Translational Medicine. 18(1). 371–371. 12 indexed citations

Jasinski‐Bergner, Simon, André Steven, & Barbara Seliger. (2020). The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis. International Journal of Molecular Sciences. 21(15). 5209–5209. 16 indexed citations

Wickenhauser, Claudia, Daniel Bethmann, Zipei Feng, et al.. (2019). Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune Cells. Methods in molecular biology. 1913. 13–31. 13 indexed citations

Steven, André, Jiaoti Huang, Daniel Branstetter, et al.. (2018). Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 36(11). 502.e15–502.e24. 5 indexed citations

10.

Steven, André & Barbara Seliger. (2018). The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer. Breast Care. 13(1). 16–21. 122 indexed citations

11.

Steven, André, Claudia Wickenhauser, Dimitrios Mougiakakos, et al.. (2017). Linking CREB function with altered metabolism in murine fibroblast-based model cell lines. Oncotarget. 8(57). 97439–97463. 16 indexed citations

12.

Steven, André, et al.. (2017). Receptor activator of NFκB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinoma. European Urology Supplements. 16(3). e1721–e1722. 1 indexed citations

13.

Wickenhauser, Claudia, et al.. (2017). Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells. OncoImmunology. 7(4). e1373233–e1373233. 16 indexed citations

14.

Steven, André & Barbara Seliger. (2016). Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target. Oncotarget. 7(23). 35454–35465. 103 indexed citations

15.

Steven, André, Bernhard Hiebl, Claudia Wickenhauser, et al.. (2016). Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization. Oncotarget. 7(32). 52061–52084. 10 indexed citations

16.

Steven, André, Christian V. Recktenwald, Bernhard Hiebl, et al.. (2015). Colorectal Carcinogenesis: Connecting K-RAS–Induced Transformation and CREB Activity In Vitro and In Vivo. Molecular Cancer Research. 13(8). 1248–1262. 23 indexed citations

17.

Mao, Yumeng, Dhifaf Sarhan, André Steven, et al.. (2014). Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity. Clinical Cancer Research. 20(15). 4096–4106. 225 indexed citations

18.

Steven, André, Chiara Massa, Manuela Iezzi, et al.. (2013). HER-2/neu Mediates Oncogenic Transformation via Altered CREB Expression and Function. Molecular Cancer Research. 11(11). 1462–1477. 30 indexed citations

19.

Recktenwald, Christian V., André Steven, Kousaku Mimura, et al.. (2012). HER-2/neu-mediated Down-regulation of Biglycan Associated with Altered Growth Properties. Journal of Biological Chemistry. 287(29). 24320–24329. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact